adipose derived stem cells in adipose derived stem cells
play

Adipose derived stem cells in Adipose derived stem cells in - PowerPoint PPT Presentation

Adipose derived stem cells in Adipose derived stem cells in endometrial cancers Ann Klopp, MD PhD Advances in Endometrial Cancer Epidemiology and Biology March 18 th , 2014 Tumor Stroma Where does it come from? Bone marrow origin of tumor


  1. Adipose derived stem cells in Adipose derived stem cells in endometrial cancers Ann Klopp, MD PhD Advances in Endometrial Cancer Epidemiology and Biology March 18 th , 2014

  2. Tumor Stroma Where does it come from?

  3. Bone marrow origin of tumor Bone marrow origin of tumor stroma stroma β -gal Tg RAG-1 -/- , H-2b / BMT XRT Pancreas SCID Ca S.C. H-2d 4 wks 2-4 wks 40% of the myofibroblasts in the cancer-induced stroma were of BM origin at 4 f X-gal weeks. Ishii et al, BBRC, 309:232, 2003

  4. MSC/ASC MSC/ASC Therapeutic  Immune modulation for Marrow stromal cells/ hematopoetic transplantion Adipose stromal cells  Tissue engineering  Tissue engineering Mesenchymal stem cells Definition  Plastic adherent l dh Resident and circulating  Mesenchymal markers  Bone marrow  Multipotent  Fat Characteristics Endogenous functions g Cells can can be readily, s c c b d y,  Support hematopoesis expanded and restransplanted.  Wound repair Migrate to sites of injury and tumors

  5. Bone-marrow derived MSC engraft in MDA231 Breast Metastasis Murine Lungs with MDA231 metastasis g Normal Murine Lungs g Studeny, Marini, et al., Vol. 96, No. 21, November 3, 2004

  6. Adipose is also a source of MSC/ASC Adipose is also a source of MSC/ASC which form tumor which form tumor stroma hi h f hi h f t t stroma t Zhang, Kolonin Cancer Research 2009

  7. Kidd Plos 2012

  8. Does obesity increase ASC Does obesity increase ASC engraftment? engraftment? f f ? ? Tumors in obese mice contain more ASC marker positive cells Tumors in obese mice contain more ASC marker positive cells Zhang, Kolonin Cancer Research 2012

  9. Hypothesis: visceral adipose tissue Hypothesis: visceral adipose tissue provides provides ASC to id id ASC ASC ASC to intraperitoneal intraperitoneal i i i i l l tumors tumors tumors tumors

  10. Visceral adiposity vs. BMI p y

  11. Visceral adiposity and endometrial Visceral adiposity and endometrial cancer risk in post-menopausal women Waist to hip ratio Waist to hip ratio RR RR < 0.74 1.0 0.74-0.78 0 74 0 78 1 09 1.09 >0.78-0.83 1.22 >0.83 1.55 P-trend 0.005 Friedenreich et al Cancer Causes Control

  12. Visceral adipose Peripheral adipose Common site of metastasis of intra- Rare metastasis abdominal cancers Increases hypergycemia, Less metabolic effects on insulin hyperinsulinemia, hyperTG, impaired resistance glucose tolerance Drains through the liver g Venous drainage through systemic veins g g y Larger adipocytes (more insulin Smaller adipocytes (higher uptake of resistance) FFA and TG) Well vascularized and innervated Less well vascularized and innervated More inflammatory cell infiltrating y g Less inflammatory cell infiltrate y Higher expression of pro-inflammatory Less inflammatory cytokines cytokines (TNF-alpha, CRP, IL-6) Accumulation supported by lower Accumulation promoted by estrogen estrogen

  13. Specimen Specimen Diagnosis Diagnosis Omentum Omentum BMI BMI Stage Stage involved OSC1 AdenoCA of - 25 Recurrent endometrium and ovary OSC2 Granulosa cell tumor of + 31.4 Recurrent the ovary sc ASC sc-ASC lipoaspirate lipoaspirate n/a n/a unknown unknown n/a n/a BM-MSC Normal bone marrow n/a unknown n/a donors Wi38 Fetal lung n/a n/a n/a

  14. Unanswered questions • Do visceral adipose derived stromal cells engraft and support endometrial cancers? engraft and support endometrial cancers? • Does the tissue source of ASC (visceral vs. subcutaneous) change the ASC phenotype? b ) h h h ? • Does obesity support cancer progression through ASC? – by altering the phenotype of ASC? – or just increasing the availability of ASC? • Is ASC population abnormal in patients with Is ASC population abnormal in patients with metastatic cancer?

  15. Mince omentum Enzymatic digestion (collagenase and dispase) for 1 hour on shaker at 37 degrees for 1 hour on shaker at 37 degrees Centrifuge and resuspend in DMEM/ 10% FBS Centrifuge and resuspend in DMEM/ 10% FBS Filter through 100 µ m and 40 µ m Nylon cell strainer Centrifuge and resuspend pellet in red cell lysis buffer Incubate in 37 degree water bath I b t i 37 d t b th Count and plate cells Count and plate cells

  16. In-vivo effects of OSC on In vivo effects of OSC on endometrial xenograft formation 1.6 x 6 10 4 cells (sc)/mouse 3x/week Klopp Clinical Cancer Research 2012

  17. In-vivo effects of O-ASC on endometrial xenograft formation Klopp Clinical Cancer Research 2012

  18. O-ASC engraft in endometrial xenografts Periphery Periphery Center Klopp Clinical Cancer Research 2012

  19. O-ASC increase tumor vascularity Klopp Clinical Cancer Research 2012

  20. O-ASC increase tumor vascularity Klopp Clinical Cancer Research 2012

  21. O-ASC increase tumor vessel maturity

  22. O-ASC increase tumor vessel maturity O ASC increase tumor vessel maturity

  23. Klopp Clinical Cancer Research 2012

  24. Klopp Clinical Cancer Research 2012

  25. Conclusions • Omental ASC promote the growth of endometrial xenografts by supporting tumor endometrial xenografts by supporting tumor vasculature. Q Questions i • Could differences in O-ASC and sc-ASC be attributed to isolation techniques?

  26. Omental vs. subcutaneous derived ASC: P i Paired clinical samples d li i l l Flouresence Flouresence F F Days after 300uM carboplatin y p Days Days

  27. Conclusion • O-ASC have similar effects as SC-ASC on endometrial cancer cell proliferation, endometrial cancer cell proliferation, migration and chemosensitivity in-vitro. Questions • Are differences in O-ASC and sc-ASC seen in- vivo? • Does obesity alter the phenotype of ASC or just increase the availability of ASC?

  28. C57 mice fed high-fat diet develop C57 mice fed high fat diet develop obesity and metabolic syndrome Injection 50 Lean Mice Obese Mice Obese Mice 40 ht (g) 30 Weig 20 10 0 0 50 100 150 132 Days

  29. Adipos e density *** 10 10 *** 8 cm ^3) 6 Volum e (c 4 2 0 Le-SC Le-V Ob-SC Ob-V

  30. ID8 ovarian cancers grow more rapidly ID8 ovarian cancers grow more rapidly in mice with diet-induced obesity t] lean lean [tota l c oun 2000000 obese 1500000 ne s c e nc e 1000000 500000 lum i 0 0 2 4 6 8 10 12 days

  31. ASC isolation Lean Obese L-V- SubQ ASC Viscera l

  32. Le-V-ASC Ob-V-ASC Le-SC-ASC Ob-SC-ASC CD29 CD34 CD31 CD11b 32

  33. Ob-V-ASC Le-V-ASC Le-SC-ASC Ob-SC-ASC CD73 CD90 CD105 CD45 33

  34. ASC proliferation ASC proliferation 2000000 Le-SC-ASC Le SC ASC Le-V-ASC 1500000 umber Ob-SC-ASC 1000000 1000000 cell nu Ob-V-ASC 500000 0 0 5 10 15 days

  35. In-vitro adipocyte differentiation p y SubQ Visceral Lean Obese adipogenesis( total OD) 100000 ** ** 80000 sity tical Den 60000 ** 40000 p O 20000 0 Lean-SC-ASC Ob-SC-ASC Lean-V-ASC Ob-V-ASC

  36. In-vitro osteocyte differentiation y SubQ Visceral Lean Obese osteogenesis(total OD) 600000 ** ** sity 400000 tical Den 200000 p p O 0 C C C C S S S S A A A A - - - - C C V V S S - - n b - - n a O b e a O L e L

  37. SubQ Visceral Obese Obese Lean Lean Lean Obese P=0.05 P=0.321 Lean Obese

  38. SubQ Visceral Lean Obese Ki67 Vessel Nuclear Ki67 in tumor 4+ pixels ** 10 * 30 ** 8 ent GSL I isolectin B4 percent Ki67 + pixels 20 6 4 10 2 p 0 0 perce C C C C 0 S S S S A A A A Le-SC Ob-SC Le-V Ob-V - - - - C C V V S S - - e b - - L O e b L O groups

  39. SubQ Visceral Lean Obese Perilipin Vessel Nuclear Perilipin (pixel) ** 4 els ercent perilipin+ pixe 3 2 1 pe 0 Le-SC-ASC Ob-SC-ASC Le-V-ASC Ob-V-ASC groups

  40. Analysis of malignant ascities ascites Macrophage in ascites 5 40 * 4 me (ml) 30 3 t cen volum erc 20 20 2 p 10 1 0 0 C C C C C C C C C C C C C C C C S S S S S S S S A A A A A A A A - - - - C C V V - - - - C C V V S - S - e b S S - - - - e L O b e b - - L O L e b O L O

  41. SubQ Visceral F4/80 Vessel Nuclear Lean Lean Obese Ob-V-ASC *** 10 * * * 4/80+ pixels 8 6 percent F4 4 2 0 Le-SC Ob-SC Le-V Ob-V

  42. MSC increase MCF-7 mammosphere formation MSC increase MCF-7 mammosphere formation MCF-7 alone 20% MSC Day 5 E-Cadherin N-Cadherin Fibronectin RhoC Tenascin Vimentin Actin Ann H.KloppPLoS One 2010

  43. ASC spheroid formation in ID8-CM 250 ** ** SubQ Visceral 200 numbers 150 100 Lean 50 0 Le-SC-CM Ob-SC-CM Le-V-CM Ob-V-CM * * 200 150 m) Obese size(u 100 50 0 Le-SC-CM Le-V-CM Ob-SC-CM Ob-V-CM Le-SC-ctrl Le-V-ctrl Ob-SC-ctrl Ob-V-ctrl

  44. ID8 spheroid formation in ASC-CM SubQ Visceral * 250 200 rs 150 e Lean b m u 100 n 50 0 C C V V l r S S - - t e b c - - L O e b L O 250 200 Obese ) m 150 (u e iz 100 s 50 0 C C V V Le-V- l Ob-V- r S S - - t e b c - - L O e b L O ASC ASC

Recommend


More recommend